Angela Hager
Medical · Farmington, WVNPI 1124299813
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AstraZeneca accounts for 62.4% of it on its own, with 37 other manufacturers making up the rest. 2025 is the largest year on record at $6,145, 3.4 times the $1,801 reported in 2021. Among medical clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 397 payments — averaging $40.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$10K
- AbbVie$1K
- Novo Nordisk$582
- Lilly USA, LLC$537
- Astellas Pharma US Inc$432
- Bayer$420
- plus $3K from 32 others
What the payments were for
- Speaking & faculty fees$8,08050%
- Travel & lodging$4913%
- Food & beverage$7,34646%
- Education$1191%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 69 | $10,002 |
| AbbVie | 81 | $1,236 |
| Novo Nordisk | 34 | $582 |
| Lilly USA, LLC | 23 | $537 |
| Astellas Pharma US Inc | 15 | $432 |
| Bayer | 18 | $420 |
| Amgen(2 entities) | 26 | $392 |
| Shield Therapeutics Inc | 7 | $277 |
| Pfizer | 15 | $256 |
| Sanofi-aventis U.S. LLC | 13 | $179 |
| Sunovion Pharmaceuticals Inc. | 11 | $170 |
| Novartis | 11 | $163 |
| Exact Sciences | 8 | $141 |
| Biohaven Pharmaceuticals, Inc. | 5 | $126 |
| Xeris Pharmaceuticals, Inc. | 7 | $124 |
| Sanofi | 1 | $100 |
| GSK | 6 | $97 |
| Boehringer Ingelheim | 6 | $92 |
| Esperion Therapeutics, Inc. | 4 | $70 |
| Dexcom, Inc. | 4 | $70 |
| Kowa Pharmaceuticals America, Inc. | 4 | $57 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $55 |
| Merck | 4 | $50 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Mylan Specialty L.p. | 2 | $37 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Amarin Pharma, Inc. | 2 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Viatris Specialty LLC | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Lexicon Pharmaceuticals, Inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $14 |
| Si-bone, Inc. | 1 | $14 |
| Vivus LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,036 in reported general payments places this provider in the 95th percentile of 233 medical providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 97 | $98,685 |
| EliquisApixaban | 75 | $58,658 |
| MounjaroTirzepatide | 54 | $56,093 |
| JanuviaSitagliptin Phosphate | 39 | $42,514 |
| JardianceEmpagliflozin | 40 | $34,657 |
| TrulicityDulaglutide | 20 | $31,357 |
| FarxigaDapagliflozin Propanediol | 33 | $29,778 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $29,513 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 39 | $29,123 |
| XareltoRivaroxaban | 25 | $23,163 |
| Repatha SureclickEvolocumab | 30 | $22,652 |
| VascepaIcosapent Ethyl | 31 | $18,963 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 19 | $16,669 |
| MyrbetriqMirabegron | 30 | $14,037 |
| KerendiaFinerenone | 13 | $12,263 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $582 | $98,68597 claims |
| Lilly USA, LLCMounjaro, Trulicity | $537 | $87,45074 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $10,002 | $65,958103 claims |
| PfizerEliquis | $256 | $58,65875 claims |
| MerckJanuvia | $50 | $42,51439 claims |
| Boehringer IngelheimJardiance | $92 | $34,65740 claims |
| GSKTrelegy Ellipta | $97 | $29,51338 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $179 | $16,66919 claims |
| Astellas Pharma US IncMyrbetriq | $432 | $14,03730 claims |
| BayerKerendia | $420 | $12,26313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 233 medical providers in West Virginia.
Other medical in Farmington
- Katherine BoggsSouth Charleston$46K
- Lowell LarewMorgantown$31K
- Katie CarpenterSouth Charleston$26K
- Lauren DillonBeckley$18K
- Brandon CaragCharleston$16K
- Scott EthridgeCharleston$16K
- Kellie HanselSouth Charleston$12K
- Matthew MaynardElkins$10K
- Mohammad YousafCharleston$9K
- Gregory McCartneyCharleston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.